These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34880044)

  • 21. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
    Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
    Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
    N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status.
    Long AJ; Kaur P; Lukey A; Allaire C; Kwon JS; Talhouk A; Yong PJ; Hanley GE
    Am J Obstet Gynecol; 2023 Jan; 228(1):57.e1-57.e18. PubMed ID: 36029832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
    Parker WH; Feskanich D; Broder MS; Chang E; Shoupe D; Farquhar CM; Berek JS; Manson JE
    Obstet Gynecol; 2013 Apr; 121(4):709-716. PubMed ID: 23635669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation.
    Kotsopoulos J; Hall E; Finch A; Hu H; Murphy J; Rosen B; Narod SA; Cheung AM
    JAMA Netw Open; 2019 Aug; 2(8):e198420. PubMed ID: 31390031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-hospital complications of bilateral salpingo-oophorectomy at benign hysterectomy: a population-based cohort study.
    Lai JC; Chen HH; Chu KH; Wang KL; Huang N; Hu HY; Chou YJ
    Menopause; 2017 Feb; 24(2):187-195. PubMed ID: 27779566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All-cause and cardiovascular mortality after hysterectomy and oophorectomy in a large cohort (HUNT2).
    Michelsen TM; Rosland TE; Åsvold BO; Pripp AH; Liavaag AH; Johansen N
    Acta Obstet Gynecol Scand; 2023 Apr; 102(4):465-472. PubMed ID: 36814418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
    Obermair A; Youlden DR; Baade PD; Janda M
    Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients.
    Oseledchyk A; Gemignani ML; Zhou QC; Iasonos A; Elahjji R; Adamou Z; Feit N; Goldfarb SB; Long Roche K; Sonoda Y; Goldfrank DJ; Chi DS; Saban SS; Broach V; Abu-Rustum NR; Carter J; Leitao M; Zivanovic O
    Int J Gynecol Cancer; 2021 Feb; 31(2):222-231. PubMed ID: 33273020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation.
    Wong J; Murji A; Sunderji Z; Chow O; Shapiro J; Wolfman W; Shirreff L
    Menopause; 2020 Sep; 28(1):8-11. PubMed ID: 32898023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid cancer risk in women after hysterectomy: A nationwide cohort study.
    Tai TS; Tsai CF; Yang HY
    Maturitas; 2024 Jul; 185():107980. PubMed ID: 38555761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
    Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
    Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
    Miller H; Pipkin LS; Tung C; Hall TR; Masand RP; Anderson ML
    J Minim Invasive Gynecol; 2017; 24(5):772-776. PubMed ID: 28285055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Assaf W; Andraous M; Lavie O; Segev Y
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salpingo-oophorectomy or surveillance for ovarian endometrioma in asymptomatic premenopausal women: a cost-effectiveness analysis.
    Orlando MS; Cadish LA; Shepherd JP; Falcone T; Chang OH; Kho RM
    Am J Obstet Gynecol; 2022 Aug; 227(2):311.e1-311.e7. PubMed ID: 35490792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal hysterectomy with or without bilateral salpingo-oophorectomy may be an alternative treatment for endometrial cancer patients with medical co-morbidities precluding standard surgical procedures: a systematic review.
    Kruse AJ; Ter Brugge HG; de Haan HH; Van Eyndhoven HW; Nijman HW
    Int J Gynecol Cancer; 2019 Feb; 29(2):299-304. PubMed ID: 30659027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.
    Lee YC; Bressel M; Grant P; Russell P; Smith C; Picken S; Camm S; Kiely BE; Milne RL; McLachlan SA; Hickey M; Friedlander ML; Hopper JL; Phillips KA;
    Fam Cancer; 2017 Oct; 16(4):461-469. PubMed ID: 28285341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.